|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/26/21 Annovis Bio, Inc. 25 11/26/21 1:11K Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 25 Notice by an Issuer of the Removal from Listing HTML 8K
and Registration on a Securities Exchange of
Matured, Redeemed or Retired Securities
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 25
NOTIFICATION OF REMOVAL FROM LISTING AND/OR
REGISTRATION UNDER SECTION 12(b) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-39202
ANNOVIS BIO, INC.
NYSE American
(Exact name of Issuer as specified in its charter, and name of Exchange
where security is listed and/or registered)
1055 Westlakes Drive, Suite 300
(Address, including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
Common Stock, par value $0.0001 per share
(Description of class of securities)
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
¨ 17 CFR 240.12d2-2(a)(1)
¨ 17 CFR 240.12d2-2(a)(2)
¨ 17 CFR 240.12d2-2(a)(3)
¨ 17 CFR 240.12d2-2(a)(4)
¨ Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.1
x Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant to the requirements of the Securities Exchange Act of 1934, Annovis Bio, Inc. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused the notification to be signed on its behalf by the undersigned duly authorized person.
| Date: November 26, 2021 | By: | /s/ Jeffrey McGroarty |
| Name: Jeffrey McGroarty | ||
| Title: Chief Financial Officer |
| 1 | Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions. |
C:
| This ‘25’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / Effective on: | 11/26/21 | None on these Dates | ||
| List all Filings | ||||